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doi:10.1016/j.joca.2010.05.001Research ﬁndings are unavoidably uncertain. They typically rely
on fragmentary information from samples evaluated using statis-
tical inference. Statistical inference is, however, a tool for assessing
the degree of uncertainty of a ﬁnding, not for proving that a ﬁnding
is true. Consequently, many published ﬁndings are false1,2.
All ﬁndings thus deserve to be treated critically, and scientiﬁc
journals should try better to facilitate the readers’ understanding
of theﬁndings’uncertainty3,4. In the followingwegive some sugges-
tions for manuscript authors (and readers) of Osteoarthritis and
Cartilage in order to facilitate a better understanding of these issues.
Prompted by incidents of images in manuscripts submitted to
Osteoarthritis and Cartilage not representing the full picture, the
editors also take this opportunity to comment on current recom-
mendations for preparing images for publication in Osteoarthritis
and Cartilage.Statistics in materials and methods
Statistical tests differ qualitatively from chemical tests. While
chemical tests relate to the properties of a studied sample only,
a statistical test concerns generalization of information collected
from a sample to unstudied subjects, animals or specimens. This
procedure often requires detailed information to be adequately
described, much more than the name only of a statistical hypoth-
esis test presented in a ﬁgure legend. Manuscripts should therefore,
with few exceptions, have a separate statistics part in the methods
section, where all statistical methods are described in sufﬁcient
detail to allow a reproduction of the results, given access to the
original raw data.
When the methods used are based on certain assumptions
(Student’s t-test and ANOVA are for example based on the assump-
tions of independent observations, Gaussian distribution and
homogeneity of variance), it should be investigated whether these
assumptions are fulﬁlled or not. This investigation and its outcome
should be described in the manuscript.
If serious departures from the assumptions are detected, alterna-
tive statistical methods should be considered. When observations
are correlated instead of being independent, such as right and left
knee of a patient, mixed or marginal models could, for example, be
used. When the distribution of data is skewed, and no alternative
analysis method is available, the consequences of violating theResearch Society International. Puassumptions should be evaluated and described. Sensitivity tests
using different scenarios is one way to do this.
Many, if not all, manuscripts include statistical analyses gener-
ating more than one P-value. Both multiple testing of the same
endpoint (for example of differences between multiple groups of
differently treated patients or between two groups at multiple
visits during follow-up) and testing of several different endpoints
or outcomes is common. Repeated testing may inﬂate the false
positive error rate substantially above the nominal signiﬁcance
level, and methods for correcting the P-values have therefore
been developed. The Bonferroni method is probably the best
known, but the methodology has been improved and better alter-
natives are available, such as closed testing procedures and the
Sidak–Holm procedure5.
P-values inﬂated by multiplicity are acceptable in exploratory or
hypothesis generating studies, because the result of these studies is
simply a new hypothesis, and should be declared as such. In an
experiment or trial performed to conﬁrm a pre-speciﬁed hypoth-
esis, however, the nominal level of statistical signiﬁcance is crucial;
multiplicity issues must be addressed adequately.
The aim of the study (as of exploration or conﬁrmation) should
thus be made clear to the reader at the outset, and when the
purpose is conﬁrmation, a clear overall strategy for protecting
against false positive errors should be presented. It will also facili-
tate for the reader if multiplicity corrections performed in explor-
atory studies are motivated.
Statistics in results
The Materials and methods section should include only infor-
mation that was available at the time when the study protocol
was written or experiment was planned. Information obtained
during the study should be presented in the Results section.
Variability or uncertainty
The Results section will usually include both a description of
observed data and the investigators’ interpretation of these data.
It is important that investigators distinguish between these two
different aspects. However, many manuscripts reveal confusion
instead, especially in ﬁgures. Generalizations can, for example, be
presented with standard deviation (SD), which is a measure ofblished by Elsevier Ltd. All rights reserved.
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mean (S.E.M.), a measure of inferential uncertainty.
Observed data should be described to show if the observations
have reasonable values, if there are outliers indicating clerical
errors in the data collection, if assumptions of Gaussian distribution
are reasonable, if variability is homogeneous, if potential confound-
ing factors (like age, sex, smoking habits, etc.) are balanced
between groups or require adjustment of the results.
Interpretation of data, on the other hand, should take into
account the uncertainties caused by sampling and measurement
of the observed data, because when generalizing the results to
other subjects or animals than those examined, individual vari-
ability and measurement errors will play very important roles6. In
fact, this is one of the most fundamental differences between
case reports written before the 1950s and modern scientiﬁc
medical reports.
The incidence of a certain disease in a group of patients or
animals, the relative fracture rate among patients or animals
treated or untreated with a speciﬁc substance, differences between
animals of different strains, the difference in serum biomarker
levels between patients with and without osteoarthritis, are exam-
ples of ﬁndings which need to be interpreted with respect to this
kind of uncertainty.
The S.E.M. is an uncertainty measure. It corresponds to a 68%
conﬁdence interval for the estimate of an unknown value. However,
95% conﬁdence intervals are preferred, as they preserve the consis-
tency with hypothesis tests performed at the 5% signiﬁcance level,
the alternative method for uncertainty evaluation.
Conﬁdence intervals have the advantage over hypothesis tests
that they describe a range of likely values. While statistically insig-
niﬁcant hypothesis tests only indicate absence of evidence, not
evidence of absence, the corresponding 95% conﬁdence interval
describes a range of likely values that may serve as evidence of
absence of values excluded from this interval.
It should, however, be noted that graphical assessment of statis-
tical signiﬁcance between differences in group means by
comparing conﬁdence intervals is not unproblematic. While non-
overlapping conﬁdence intervals always corresponds to a statisti-
cally signiﬁcant difference, overlapping conﬁdence intervals do
not necessarily indicate statistical insigniﬁcance7. The reason for
the inconsistency is that distance from the mean is calculated
differently in Student’s t-test and in the conﬁdence intervals. It
may therefore be pertinent to present both P-values and conﬁdence
intervals, or, for avoiding P-values, to present group differences
with conﬁdence intervals for the difference in mean values, not
for the two mean values themselves.
The question of whether error bars in a particular ﬁgure should
reﬂect data description (with SD or percentiles) or interpretation
(with 95% conﬁdence intervals for mean or median values) may
seem problematic to answer. However, when the purpose is to
describe the characteristics of observed data, for example
a Gaussian or skewed distribution, the frequency of outliers or
the balance of potential confounding factors, SDs or percentiles
should be used to describe variability. If the purpose instead is to
describe and compare the mean treatment effects in different
groups or a dose–response relation, 95% conﬁdence intervals
should be used to present the uncertainty in the estimated effects.
Signiﬁcance
An analogous problem is the common and unspeciﬁc use of the
word “signiﬁcant”, which has at least two fundamentally different
meanings: (1) the clinical or practical signiﬁcance of an effect or
difference for the subjects affected by it, and (2) the statistical
signiﬁcance or the uncertainty of whether an observed effect ordifference is caused by chance or not. A clinically signiﬁcant effect
may well be statistically insigniﬁcant and vice versa. Just stating
that an effect is “signiﬁcant” is thus ambiguous. Specify if statistical
or clinical/practical signiﬁcance is referred to. If clinical or practical
signiﬁcance is what is meant, consider using ‘relevant’, ‘important’
or ‘meaningful’ instead, and when statistical signiﬁcance is meant,
consider using ‘likely’ or ‘probable’ instead.
Results are too often presented in terms of whether a differ-
ence or effect is statistically signiﬁcant or not. This leads to an
artiﬁcial dichotomy of results suffering from one by multiplicity
inﬂated false positive error rate and an ignored false negative
error rate.
The general rule should be to present quantiﬁed results, esti-
mates of true effects or differences in practical terms, e.g., length,
height, width, weight, volume, etc., together with an indicator of
the uncertainty of the estimate (preferably a 95% conﬁdence
interval as this describes the statistical precision better than a P-
value). However, if a hypothesis test is preferred instead of a conﬁ-
dence interval, the P-value should be presented precisely, i.e.,
unless P< 0.001 as P¼ 0.035, not as P< 0.035 or P< 0.05 and never
as P> 0.05, n.s. or as P¼ 0.000.
Number of observations
The number of observations should be clearly stated for each
test or estimate. When repeated or multiple measurements are
made on the same subject or animal or Petri dish, both the number
of independent observations and repeated observations should be
presented.
Graphs and tables
Figures are valuable when they present complex results in
a readable way. However, much information can be presented
more clearly and with less space in a table. The information usually
described in bar charts is, for example, often better presented in
a table.
The principles for presenting observations and interpretations
of data, discussed above, remain, however. They are independent
of whether a graph or a table is used for the presentation.We there-
fore emphasize: for ﬁgures the current use of S.E.M. in error bars
should be replaced by 95% conﬁdence intervals to describe
uncertainty.
The picture, the whole picture and nothing but the picture?
Good science requires reliable data, and even then we may as
scientists too often be proven wrong1,2. Images of gels, immuno-
chemistry, microscopy, radiographs, magnetic resonance, ultra-
sound and more form an important part of the data presentation
in many manuscripts submitted to Osteoarthritis and Cartilage.
Prompted by incidents of images in manuscripts submitted to the
journal not representing the picture, the whole picture and nothing
but the picture, we take this opportunity to comment on what is
commonly termed image manipulation. This appears to be disturb-
ingly frequent, and has led to numerous editorial comments in
other journals, see for example8–12. Some instances of image
manipulation may be caused by a lack of understanding or knowl-
edge of the dos and don’ts when preparing images for publication.
However, this excuse is wearing increasingly thin in the current
reality of widely published high proﬁle cases of image manipula-
tion and blot doctoring, and the immediate internet availability of
author guidance in these matters, such as for Osteoarthritis and
Cartilage http://www.elsevier.com/wps/ﬁnd/journaldescription.
cws_home/623055/authorinstructions.
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ware in our computers. But many of the modiﬁcations possible
are incompatible with good science, and may represent data falsi-
ﬁcation or fabrication, leading to a serious accusation of scientiﬁc
misconduct. The result might be the retraction of published work,
and worse in the form of a career disruption. Co-authors share
full responsibility in these cases. As noted, the editors of OAC
have come across some recent instances, taking far too much
time, effort and grief for all involved to resolve. Time better spent
doing good science.
A good summary rule is provided by the following quote from
the article by Rossner and Yamada in the Journal of Cell Biology8:
“No speciﬁc feature within an image may be enhanced, obscured,
moved, removed, or introduced. The grouping of images from
different parts of the same gel, or from different gels, ﬁelds, or expo-
sures must be made explicit by the arrangement of the ﬁgure (e.g.,
using dividing lines) and in the text of the ﬁgure legend. Adjustments
of brightness, contrast, or color balance are acceptable if they are
applied to the whole image and as long as they do not obscure or
eliminate any information present in the original. Nonlinear adjust-
ments (e.g., changes to gamma settings) must be disclosed in the
ﬁgure legend.”
Authors are advised to read this article and the other articles
cited below in full, as well as the OAC guide for authors before
submission of a manuscript containing images.
And don’t forget: it is absolutely critical that you archive and
time stamp your original raw data and images as they are
collected. This allows you to verify accuracy should the need
ever arise. Without the original data or images you are lost;
should your published results ever be questioned, you cannot
prove yourself right.Author contributions
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